BioSpace News Archive

Biotech Bay

CymaBay Announces Proposed Public Offering of Common Stock

CymaBay anticipates using the net proceeds from the offering to fund ongoing development of seladelpar and for working capital and general corporate purposes.

January 30, 2018
·
3 min read
Auris Medical Announces Pricing of $5.5M Registered Direct Offering

The Company also agreed to issue warrants to purchase up to an aggregate of 7,499,999 common shares to the investors in a concurrent private placement.

January 30, 2018
·
4 min read
Business

Amarin Announces Proposed Public Offering of American Depositary Shares

On January 26, 2018, the last sale price of the ADSs on The NASDAQ Global Market was $4.27 per share.

January 30, 2018
·
4 min read
Genetown

Albireo Announces Closing of $74.8M Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

Cowen and William Blair acted as joint book-running managers and representatives of the underwriters for the offering.

January 30, 2018
·
2 min read
Pharm Country

Misonix to Report Fiscal 2018 Second Quarter Financial Results, Host Conference Call and Webcast on February 6

The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Both the call and webcast are open to the general public.

January 30, 2018
·
1 min read
Business

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018

A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

January 30, 2018
·
1 min read
Business

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as CFO

Mark will officially commence in his role as Chief Financial Officer of Dova on January 31st, 2018.

January 30, 2018
·
3 min read
BioMidwest

Nu-Med Plus Announces Trading on OTCQB Marketplace

The OTCQB market offers well informed and extremely efficient trading for companies and investors.

January 30, 2018
·
2 min read
Business

ImmuCell Appoints Two New Members to Its Board of Directors

Mr. Steven T. Rosgen and Ms. Bobbi Jo Brockmann were appointed to its Board of Directors effective immediately.

January 30, 2018
·
5 min read
Business

Vetter Initiates Reconstruction Activity at its Recently Purchased Des Plaines Site

Vetter announced today that initial reconstruction work on the 18 acres Des Plaines site purchased earlier this year is scheduled to begin this month.

January 30, 2018
·
2 min read